AbbVie
ABBV
#27
Rank
$369.01 B
Marketcap
$209.03
Share price
1.96%
Change (1 day)
17.43%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total assets

Total assets on the balance sheet as of December 2024 : $135.16 Billion USD

According to AbbVie's latest financial reports the company's total assets are $135.16 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

AbbVie - Total assets on balance sheet (from 2011 to 2024)

Total assets by year

Year Total assets Change
2023-12-31$134.71 B-2.95%
2022-12-31$138.80 B-5.27%
2021-12-31$146.52 B-2.68%
2020-12-31$150.56 B68.96%
2019-12-31$89.11 B50.15%
2018-12-31$59.35 B-16.15%
2017-12-31$70.78 B7.09%
2016-12-31$66.09 B24.6%
2015-12-31$53.05 B92.82%
2014-12-31$27.51 B-5.77%
2013-12-31$29.19 B8.11%
2012-12-31$27.00 B38.35%
2011-12-31$19.52 B-7.64%
2010-12-31$21.13 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
$219.47 B 62.38%๐Ÿ‡บ๐Ÿ‡ธ USA
$92.60 B-31.49%๐Ÿ‡บ๐Ÿ‡ธ USA
$78.71 B-41.76%๐Ÿ‡บ๐Ÿ‡ธ USA
$91.83 B-32.05%๐Ÿ‡บ๐Ÿ‡ธ USA
$54.52 B-59.66%๐Ÿ‡บ๐Ÿ‡ธ USA
$28.04 B-79.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$77.68 B-42.52%๐Ÿ‡ฌ๐Ÿ‡ง UK
$104.03 B-23.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.71 B-97.25%๐Ÿ‡บ๐Ÿ‡ธ USA